Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marianne Borloo is active.

Publication


Featured researches published by Marianne Borloo.


European Journal of Medicinal Chemistry | 1997

Pyrrolidides: synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV

Koen Augustyns; Anne-Marie Lambeir; Marianne Borloo; I. De Meester; Irina Vedernikova; G. Vanhoof; Dirk Hendriks; Simon Scharpé; A. Haemers

Summary Dipeptidyl peptidase IV cleaves specifically the peptide bond at the carboxyl side of a proline at the penultimate N-terminal position of a peptide. It is thought to be important for the regulation of biologically active peptides. Moreover, it has been identified as an activation marker of T-lymphocytes (CD26). Pyrrolidides and thiazolidides are known as reversible inhibitors of DPP IV. Several homologues, unsaturated, open and 3-substituted analogues were synthesized in order to determine the structure-activity relationship of the P-1 site. l -Isoleucine was taken as P-2 amino acid. 1-( l -Isoleucyl)-3( S )-fluoropyrrolidine is about as active as the non-fluorinated compound and behaves as a competitive inhibitor. Other changes decrease or abolish the activity.


Biochimica et Biophysica Acta | 1996

Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV

Anne-Marie Lambeir; Marianne Borloo; I. De Meester; A. A. Belyaev; Koen Augustyns; Dirk Hendriks; Simon Scharpé; A. Haemers

A number of dipeptide diphenyl phosphonate esters were studied as inhibitors of dipeptidyl peptidase IV, focusing on the role of the P2 residue in the inactivation process. The active compounds were slow irreversible inhibitors of the catalytic activity of the enzyme. With proline (or alanine) in the P1 position, the rate constants of inactivation correlated with the acylation rate constants reported for homologous dipeptide derived substrates. The kinetic data indicate that the mechanism of inhibition consists of the formation of a fairly weak initial complex, followed by a slow irreversible inactivation step. This indicates that, as in the case of trypsin-like proteinases, dipeptide diphenyl phosphonate esters form a covalent adduct with the catalytic site of DPP IV, even though this enzyme belongs to a completely distinct class of serine peptidases. Enantioselectivity and secondary specificity further support the evidence that diphenyl phosphonate esters are mechanism-based inhibitors. The dipeptide diphenyl phosphonate esters had a half-life of 3-10 h at 37 degrees C in Tris buffer. The inhibitors were degraded in human plasma, depending on the type of amino-terminal amino acid. The compound with proline in the P2 position was the most resistant to degradation in plasma. Due to their stability and the irreversible nature of the inhibition, the diphenyl phosphonate esters promise to be useful tools in the continuing investigation of the physiological function of dipeptidyl peptidase IV.


Bioorganic & Medicinal Chemistry Letters | 1996

Phosphonic acid and phosphinic acid tripeptides as inhibitors of glutathionylspermidine synthetase

Christophe Verbruggen; Sofie De Craecker; Padinchare Rajan; Xian-Yun Jiao; Marianne Borloo; Keith Smith; Alan H. Fairlamb; Achiel Haemers

Abstract A series of phosphonic and phosphinic acid derivatives of glutathione were synthesized as potential inhibitors of glutathionylspermidine synthetase, an essential enzyme in the biosynthesis of trypanothione in trypanosomatids. The compounds showed moderate activity.


Tetrahedron Letters | 1995

A new synthetic method for proline diphenyl phosphonates

A. A. Belyaev; Marianne Borloo; Koen Augustyns; Anne-Marie Lambeir; Ingrid De Meester; Simon Scharpé; Norbert Blaton; O. M. Peeters; Camiel De Ranter; Achiel Haemers

Abstract The diphenyl ester of the phosphonic acid analogue of proline and related dipeptides were prepared by a reaction of the corresponding N-substituted 4-aminobutyraldehyde and triphenyl phosphite. Diastereoisomers were separated and their configuration determined by X-ray crystallography.


Bioorganic & Medicinal Chemistry Letters | 1995

Synthesis of peptidyl acetals as inhibitors of prolyl endopeptidase

Koen Augustyns; Marianne Borloo; A. A. Belyaev; Padinchare Rajan; Filip Goossens; Dirk Hendriks; Simon Scharpé; Achiel Haemers

Several acyclic and cyclic dipeptidyl acetals were synthesized. Among these, N-[N-benzyloxycarbonyl-(S)-prolyl]-(S)-prolinal dimethyl acetal 8 was shown to be a potent inhibitor of prolyl endopeptidase.


Letters in peptide sciences | 1995

Synthesis and evaluation of azaproline peptides as potential inhibitors of dipeptidylpeptidase IV and prolyl oligopeptidase

Marianne Borloo; Koen Augustyns; A. A. Belyaev; I. De Meester; Anne-Marie Lambeir; F. Goossens; Willy Bollaert; Padinchare Rajan; Simon Scharpé; A. Haemers

A series of azaproline dipeptides with various N-substituents were synthesized as possible active-site-directed inhibitors of two proline-specific serine proteases, dipeptidyl peptidase IV and prolyl oligopeptidase. Compounds with semicarbazide, carbazate, acylhydrazine and sulphonylhydrazine structures were tested. Some compounds show moderate activity, i.e., in the millimolar range.


Tetrahedron Letters | 1994

A new method for the preparation of 2-pyrrolidinylphosphinic acid and homologues

Xian-Yun Jiao; Marianne Borloo; Christophe Verbruggen; Achiel Haemers

Abstract 2-Pyrrolidinylphosphinic acid has been synthesized in a one pot reacion in 90% yield from 1-pyrroline trimer and bis(trimethylsilyl) phosphonite. The same procedure has been applied for the preparation of the piperidine and perhydroazepine homologues.


Archive | 1995

Purification of serine proteases and synthetic inhibitors thereof

Koen Jan Ludovicus Augustyns; G. Vanhoof; Marianne Borloo; Meester Ingrid Anna Jozef De; F. Goossens; Achiel Haemers; Dirk Hendriks; Anne-Marie Virginie Renée Lambeir; Simon Lodewijk Scharpe


Archive | 1995

Serine proteases, their activity and their synthetic inhibitors

Koen Jan Ludovicus Augustyns; G. Vanhoof; Marianne Borloo; Ingrid De Meester; F. Goossens; Achiel Haemers; Dirk Hendriks; Anne-Marie Virginie Renée Lambeir; Simon Lodewijk Scharpe


Synthesis | 1994

A novel synthetic route to 1-aminoalkylphosphinic acids

Xian-Yun Jiao; Christophe Verbruggen; Marianne Borloo; Willy Bollaert; Alex De Groot; Roger Dommisse; Achiel Haemers

Collaboration


Dive into the Marianne Borloo's collaboration.

Top Co-Authors

Avatar

Achiel Haemers

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Simon Lodewijk Scharpe

Rega Institute for Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge